Health Care Innovation
Blog
Learn about case that could threaten medical innovation
PRI Files Amicus Brief in Key State Supreme Court Case That Could Upend Future Medical Innovation in California
In the case, the plaintiffs filed cases against the Gilead pharmaceutical company over the company’s failure to bring an alternative medication used to treat AIDS, hepatitis, and other diseases to the marketplace called TAF under a speedier timeline, even though TAF and the originally developed medicine called TDF are both ...
Commentary
Learn more about California's doctor shortage
California needs more than medical schools to solve doctor shortage
California doesn’t have enough doctors. This year, the state met just 54% of its primary care needs. It would take 881 more physicians to eliminate all the state’s designated primary care shortage areas, where more than 5.8 million Californians currently reside. California’s leaders are trying to conjure up more physicians. ...
Commentary
Learn more about how Harris' plan might promote healthcare fraud
Will Harris’ Promises of New Era for Healthcare Invite Fraud?
For a former prosecutor and Calif. Atty. Gen. Kamala Harris sure seems to have a laissez-faire attitude toward fraud. In the race to enroll as many Americans as possible in Medicaid and in Obamacare exchange plans, the Biden-Harris administration has looked the other way as millions of Americans receive publicly ...
Commentary
Learn more about how competition can lower premiums
Competition Is The Cure For Rising Health Insurance Premiums
The presidential election is just a week away. And the rising prices of many products and services are on voters’ minds. Just over 40% of Americans say inflation is their biggest concern heading into November, according to a recent survey. In few markets are rising prices more apparent than in ...
Blog
Learn how drug price controls hurt patients, innovation
Senator Sanders’ Price Controls Will Harm Patients
In a patently politicized press release, Senator Bernie Sanders (I-VT) who is Chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, claims that the U.S. price of Ozempic is too high. As evidence, he cites generic companies that claim they can sell Ozempic for less than $100 a ...
Commentary
Read the latest on Biden administration's drug price controls
Drug Price Controls Underperform, Unworkable
According to the White House, the program will save the federal government an estimated $6 billion in 2026, the first year the new prices will be in effect, while reducing costs for seniors by $1.5 billion. Those figures might seem impressive. But they are almost certainly inflated. In fact, it’s ...
Commentary
Learn about the damage from lawsuit abuse
Tort Abuses Threat To Innovation And Product Availability
Not only is continued invention necessary for expanding our prosperity, but it is also key for mitigating problems such as global climate change or finding new technologies and treatments for troubling health conditions. Take the state and municipal lawsuits being filed against energy companies as an example. When announcing his ...
Commentary
How the GOP can get tough on health care
Nearly eight in 10 Americans worry “a great deal” or “a fair amount” about the availability and affordability of health care, according to polling from Gallup. So it’s surprising that the Republican Party’s platform this year doesn’t devote much space to the topic. It’s even largely silent on the Biden-Harris administration’s ...
Commentary
Biden’s Disdain for Democracy Revealed in Backdoor Bailout
Few likely noticed when the Biden administration announced a “voluntary Part D Premium Stabilization Demonstration” late last month. The initiative aims to “test” whether a new approach to reducing premiums for Medicare prescription drug plans will “increase the efficiency and economy of services” under the program — at least according to the ...
Commentary
JD Vance’s Healthcare Record Should Give Republicans Pause
The selection of JD Vance as the Republican vice-presidential nominee has made many in the limited-government wing of the GOP squirm. Consider his record on healthcare, where he’s signaled support for more state intervention. He justifies this approach by pointing to the struggles of ordinary Americans to afford healthcare. But more government ...
Learn about case that could threaten medical innovation
PRI Files Amicus Brief in Key State Supreme Court Case That Could Upend Future Medical Innovation in California
In the case, the plaintiffs filed cases against the Gilead pharmaceutical company over the company’s failure to bring an alternative medication used to treat AIDS, hepatitis, and other diseases to the marketplace called TAF under a speedier timeline, even though TAF and the originally developed medicine called TDF are both ...
Learn more about California's doctor shortage
California needs more than medical schools to solve doctor shortage
California doesn’t have enough doctors. This year, the state met just 54% of its primary care needs. It would take 881 more physicians to eliminate all the state’s designated primary care shortage areas, where more than 5.8 million Californians currently reside. California’s leaders are trying to conjure up more physicians. ...
Learn more about how Harris' plan might promote healthcare fraud
Will Harris’ Promises of New Era for Healthcare Invite Fraud?
For a former prosecutor and Calif. Atty. Gen. Kamala Harris sure seems to have a laissez-faire attitude toward fraud. In the race to enroll as many Americans as possible in Medicaid and in Obamacare exchange plans, the Biden-Harris administration has looked the other way as millions of Americans receive publicly ...
Learn more about how competition can lower premiums
Competition Is The Cure For Rising Health Insurance Premiums
The presidential election is just a week away. And the rising prices of many products and services are on voters’ minds. Just over 40% of Americans say inflation is their biggest concern heading into November, according to a recent survey. In few markets are rising prices more apparent than in ...
Learn how drug price controls hurt patients, innovation
Senator Sanders’ Price Controls Will Harm Patients
In a patently politicized press release, Senator Bernie Sanders (I-VT) who is Chairman of the Senate Health, Education, Labor, and Pensions (HELP) Committee, claims that the U.S. price of Ozempic is too high. As evidence, he cites generic companies that claim they can sell Ozempic for less than $100 a ...
Read the latest on Biden administration's drug price controls
Drug Price Controls Underperform, Unworkable
According to the White House, the program will save the federal government an estimated $6 billion in 2026, the first year the new prices will be in effect, while reducing costs for seniors by $1.5 billion. Those figures might seem impressive. But they are almost certainly inflated. In fact, it’s ...
Learn about the damage from lawsuit abuse
Tort Abuses Threat To Innovation And Product Availability
Not only is continued invention necessary for expanding our prosperity, but it is also key for mitigating problems such as global climate change or finding new technologies and treatments for troubling health conditions. Take the state and municipal lawsuits being filed against energy companies as an example. When announcing his ...
How the GOP can get tough on health care
Nearly eight in 10 Americans worry “a great deal” or “a fair amount” about the availability and affordability of health care, according to polling from Gallup. So it’s surprising that the Republican Party’s platform this year doesn’t devote much space to the topic. It’s even largely silent on the Biden-Harris administration’s ...
Biden’s Disdain for Democracy Revealed in Backdoor Bailout
Few likely noticed when the Biden administration announced a “voluntary Part D Premium Stabilization Demonstration” late last month. The initiative aims to “test” whether a new approach to reducing premiums for Medicare prescription drug plans will “increase the efficiency and economy of services” under the program — at least according to the ...
JD Vance’s Healthcare Record Should Give Republicans Pause
The selection of JD Vance as the Republican vice-presidential nominee has made many in the limited-government wing of the GOP squirm. Consider his record on healthcare, where he’s signaled support for more state intervention. He justifies this approach by pointing to the struggles of ordinary Americans to afford healthcare. But more government ...
